SIGHT SCIENCES, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $159.00K, a 18.88% decline year-over-year.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $93.00K, a 745.45% increase year-over-year.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $91.00K.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $57.00K, a 375.00% increase year-over-year.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $672.00K, a 89.30% increase from fiscal 2021.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $355.00K, a 1379.17% increase from fiscal 2020.
- SIGHT SCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $24.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-12-31 | $672.00K 10-K · filed 2023-03-16 | |
| 2022-06-30 | $159.00K 10-Q · filed 2022-08-11 | $400.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-03-31 | $93.00K 10-Q · filed 2022-05-10 | $437.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $355.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $57.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $196.00K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $11.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $24.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |